How effective is Artesunate for malaria?

Artesunate for malaria can be highly effective. Several studies published in 2011 indicated that he overcome Chinin, a historical gold standard for the treatment of malaria. This has led to revisions of the recommendations of some agencies that determine or form a policy related to the treatment and prevention of malaria. People receiving artesunate for malaria have a lower risk of mortality than patients on quinine and may have less side effects related to their treatment.

This drug is part of a group of drugs called artemesinins. They are Chinese in origin and are derived from plants. Studies analyzing the action of artesunate in the body suggest that they can clean the parasites quickly and efficiently, although it is also quickly metabolized. For this reason, combined therapy with a long -acting agent may be necessary to remove infection and suppress recurrence. Without a second medicine, the patient may experience flare after treatment. Aalaria is experiencing relatively limited side effects, although some studies have associated drugs with P anemia PAbout therapy. In addition, the parasites are not responsible for infection of malaria resistant to drugs. This is particularly important in the regions of the world where malaria is endemic and hard to treat because it resists commonly used medicines. These infections may be more likely to be fatal because the patient's treatment regimen may fail to check the parasites.

The drug is supplied intravenously, which requires some basic safety procedures for safe drug injection to reduce the risk of infection or other complications. Patients taking artesunate for malaria must follow care instructions to reduce the risk of recurrence. The long -term factor may be administered orally and must be used for the duration of treatment, even if the patient feels better and does not think of tinfection repeats. After the artesunate system cleans the system, sleeping parasites may occur and potentially cause the promise of malaria.

If this medicine is to DISPOZali, can be recommended for the treatment of malaria. Patients who do not have access to artesunate for malaria by conventional means can be able to register for clinical evaluation, compassionate program of use or special drug release system. Options may depend on the nation and the level of regulation. The physician can provide more information about how the patient has access to medicines that may not be available to the general public yet, as they are still undergoing an evaluation and approval process.